Creation of an Ecological Tool Assessing Episodic Memory in Geriatrics
NCT ID: NCT05668598
Last Updated: 2026-01-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
60 participants
INTERVENTIONAL
2023-03-08
2026-03-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Study test is ecological MAI. This test are assigned in two groups (with or without neurocognitive disorders).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Development, Standardisation and Standardisation Project for a New Memory Assessment
NCT06564779
Aging Stereotypes and Prodromal Alzheimer's Disease
NCT03138018
Predictive Value of Cognitive Tests Performed for the Diagnosis of Alzheimer's Disease and Related Disorders
NCT01316562
Evaluation of Screening for Visual Disorders of the Old Subject in Consultation Memory
NCT02571647
Psychometric Validation of the "Antillanisée" Version of the Mini Mental State Examination (MMSEa)
NCT03324711
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study test is ecological MAI. Participation will be 30 minutes for patients see in case of routine care and 2h30 for those accompanying the patients and participants recruited in external institutions.
Participants are assigned in two groups. Group 1 : with neurocognitive disorders Group 2 : without neurocognitive disorders
Benefits :
For participants without neurodegenerative disorder, study enables to take control early if anomaly will be detected.
The study permit to have cognitive assessment.
Risk : It's possible that participants feel tired. No constraints for participants seen during scheduled consultation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Groupe 1 : with neurocognitive disorders
with neurocognitive disorders
ecological MAI test
Neuropsychological assessment will be realize to determine presence or absence of neurodegenerative disease.
Study test is ecological MAI.
Groupe 2 : without neurocognitive disorders
without neurocognitive disorders
ecological MAI test
Neuropsychological assessment will be realize to determine presence or absence of neurodegenerative disease.
Study test is ecological MAI.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ecological MAI test
Neuropsychological assessment will be realize to determine presence or absence of neurodegenerative disease.
Study test is ecological MAI.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Person have good locomotion, move independently
* Personne agree to participate
Groupe 1 : 17≤MMSE≤24 (GRECO) Diagnosis of neurodegenerative diseases (major neurocognitive disorders: Alzheimer, mixed dementia, lobar frontotemporal degeneration, vascular dementia).
Groupe 2 : MMSE ≥ à 25 (GRECO) Without neurodegenerative disease
Exclusion Criteria
* Person deprived of liberty
* Mental retardation or MMSE≤ 16
* Understanding verbal disorders
* Visual major disturbances
* Person with disease causing increased fatigue
* Person with psychiatric pathology excepted anxiety disorder or depression with mild episodes.
* Person not covered by French national health insurance
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier de Lens
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospiralier de Lens
Lens, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-A02139-34
Identifier Type: OTHER
Identifier Source: secondary_id
2022-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.